Plasma N-acetylaspartate: Development and validation of a quantitative assay based on HPLC-MS-MS and sample derivatization

被引:8
作者
Campi, Beatrice [1 ]
Codini, Simone [2 ]
Daniele, Giuseppe [2 ]
Marvelli, Antonella [3 ]
Ceccarini, Giovanni [2 ]
Santini, Ferruccio [2 ]
Zucchi, Riccardo [3 ]
Ferrannini, Ele [1 ]
Saba, Alessandro [3 ,4 ]
机构
[1] CNR, Inst Clin Physiol, Pisa, Italy
[2] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
[3] Univ Pisa, Dept Surg Med & Mol Pathol & Crit Care Med, Pisa, Italy
[4] St Chiara Univ Hosp, Lab Clin Pathol, Pisa, Italy
关键词
N-acetylaspartate; Plasma; Derivatization; Tandem mass spectrometry; Quantification; Validation; L-ASPARTIC ACID; ACETYL-ASPARTATE; ASPARTYLGLUTAMIC ACID; BRAIN; DISEASE; DIAGNOSIS; MATRIX; MS/MS;
D O I
10.1016/j.cca.2020.05.020
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
N-acetylaspartate is a human endogenous compound synthesized by neurons, which is involved in neuronal metabolism. It is used as a marker in brain magnetic resonance spectroscopy to investigate several neurological and metabolic disorders, that can be related to a variation of its concentration with respect to reference values. N-acetylaspartate is present also in biological fluids, such as plasma, urine, and cerebrospinal fluid, where it can be quantified. Here we describe the development and validation, in compliance with the EMA guidelines, of a novel assay method for the quantification of N-acetylaspartate in plasma based on tandem mass spectrometry coupled to liquid chromatography. Its peculiarity lies in the fact that sample preparation includes an esterification step, which significantly improves the chromatographic performances and, consequently, also the method sensitivity, reproducibility and accuracy. Instrumental LLOQ is 0.06 ng/mL, i.e. at least 300 times lower than the medium N-acetylaspartate concentration in samples, accuracy is in the range 98-103%, while precision lies between 1 and 3%. The method robustness was tested in about 1000 injections of plasma samples, 96 of which were used also to assess the reference ranges in control subjects (16.46-63.40 ng/mL). Controls were then compared to plasma samples from type 2 diabetic patients. Contrary to brain magnetic resonance spectroscopy, which demonstrated a decrease in the N-acetylaspartate levels in right frontal and parieto-temporal region of type 2 diabetic patients, plasma analysis showed no statistical difference with respect to controls. However, the method here described can be profitably used in studies concerning different disorders with CNS involvement, as confirmed by reports available in the literature.
引用
收藏
页码:146 / 153
页数:8
相关论文
共 41 条
[31]   IMMUNOCYTOCHEMICAL LOCALIZATION OF N-ACETYL-ASPARTATE WITH MONOCLONAL-ANTIBODIES [J].
SIMMONS, ML ;
FRONDOZA, CG ;
COYLE, JT .
NEUROSCIENCE, 1991, 45 (01) :37-45
[32]  
Stevens H, 1999, EUR J CLIN INVEST, V29, P6
[33]   Upregulation of N-acetylaspartic Acid Induces Oxidative Stress to Contribute in Disease Pathophysiology [J].
Surendran, Sankar ;
Bhatnagar, Maheep .
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2011, 121 (06) :305-309
[34]   Parkinson's disease: oxidative stress and therapeutic approaches [J].
Surendran, Sankar ;
Rajasankar, Srinivasagam .
NEUROLOGICAL SCIENCES, 2010, 31 (05) :531-540
[35]  
TALLAN HH, 1957, J BIOL CHEM, V224, P41
[36]   Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis [J].
Teunissen, C. E. ;
Iacobaeus, E. ;
Khademi, M. ;
Brundin, L. ;
Norgren, N. ;
Koel-Simmelink, M. J. A. ;
Schepens, M. ;
Bouwman, F. ;
Twaalfhoven, H. A. M. ;
Blom, H. J. ;
Jakobs, C. ;
Dijkstra, C. D. .
NEUROLOGY, 2009, 72 (15) :1322-1329
[37]   N-ACETYLATION OF L-ASPARTATE IN THE NERVOUS-SYSTEM - DIFFERENTIAL DISTRIBUTION OF A SPECIFIC ENZYME [J].
TRUCKENMILLER, ME ;
NAMBOODIRI, MAA ;
BROWNSTEIN, MJ ;
NEALE, JH .
JOURNAL OF NEUROCHEMISTRY, 1985, 45 (05) :1658-1662
[38]   N-ACETYLASPARTATE IN NEUROPSYCHIATRIC DISORDERS [J].
TSAI, GC ;
COYLE, JT .
PROGRESS IN NEUROBIOLOGY, 1995, 46 (05) :531-540
[39]   Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder [J].
Winsberg, ME ;
Sachs, N ;
Tate, DL ;
Adalsteinsson, E ;
Spielman, D ;
Ketter, TA .
BIOLOGICAL PSYCHIATRY, 2000, 47 (06) :475-481
[40]   Altered brain metabolites in patients with diabetes mellitus and related complications - evidence from 1H MRS study [J].
Zhao, Xue ;
Han, Qing ;
Gang, Xiaokun ;
Wang, Guixia .
BIOSCIENCE REPORTS, 2018, 38